Here are four insights:
1. Conventus Orthopaedics specializes in developing devices and technology to treat fractured arm and leg bone joints.
2. With the loan closing Dec. 22, 2017, Conventus Orthopaedics plans to use the funds to continue commercial development of its fracture management system, Conventus Cage.
3. The Conventus Cage is designed for less invasive bone and joint treatments and provides patients with a quicker recovery time.
4. Other investors in Conventus Orthopaedics include Deerfield Management and Sightline Partners.
More articles on devices and implants:
Global arthroscopic devices market to exceed $1.7B by 2022: 6 notes
OrthoPediatrics launches 24th surgical system: 3 things to know
Arthrex beings headquarter expansion, to add 500+ jobs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
